Shaam Mahasneh, MD

My goal is to offer patients the latest in cataract surgery, refractive surgery and the diagnosis and treatment of corneal diseases

MANSFIELD, Texas (PRWEB)
July 08, 2020

Shaam Mahasneh, MD recently opened her ophthalmology practice, Advanced Eye and Laser Center of Mansfield, next to Methodist Medical Center in Mansfield, TX. She is a board-certified ophthalmologist with advanced training in cataract, corneal and LASIK surgery. As a native of Arlington, Texas, she brings her expertise in managing ocular disease and cutting-edge surgical techniques to the Mansfield, TX community. She is committed to providing the highest standard of care to each of her patients through personalized attention to detail, compassion and skill.

Dr. Mahasneh graduated summa cum laude from the University of Texas at Arlington and earned her Doctor of Medicine degree from the University of Texas, Southwestern Medical School. She completed her internship in general surgery at Methodist Dallas Medical Center, a high volume Level I Trauma Center and returned to UT Southwestern/Parkland Memorial Hospital to complete her ophthalmology residency training. While there, she served as Chief Resident and was accepted to their prestigious fellowship program in Cornea, External Disease and Refractive Surgery.

Dr. Mahasneh’s fellowship training gave her exceptional skills and expertise in cataract surgery, refractive surgery (LASIK, PRK), corneal transplantation (DMEK, DSAEK, PKP, DALK) and collagen cross-linking for patients who have keratoconus.

“My goal is to offer patients the latest in cataract surgery, refractive surgery and the diagnosis and treatment of corneal diseases, while giving them a good patient experience,” says Dr. Mahasneh.

Advanced Eye and Laser Center of Mansfield Services Include:

• Laser Assisted Cataract Surgery with Premium IOL Implants
• Clear Lens Extraction (CLE)
• Eyelid Surgery (Blepharoplasty)
• All-Laser LASIK
• Photo Refractive Keratectomy (PRK)
• Pterygium Removal
• Glaucoma Diagnosis and Treatment
• Dry Eye Treatment
• Diabetic Eye Care
• Eye Allergy Treatment
• Comprehensive Eye Exams

About Advanced Eye and Laser Center of Mansfield

Located in the heart of Mansfield Texas, Advanced Eye & Laser Center of Mansfield is a comprehensive ophthalmology practice encompassing every aspect of eye care. Dr. Mahasneh is a board certified, fellowship-trained ophthalmologist who provides medical and surgical management of a wide variety of eye diseases and disorders. The practice is dedicated to offering its patients the latest innovations in cataract surgery, LASIK laser vision correction and corneal diagnoses and surgery. We offer complex cataract surgery, advanced laser assisted cataract removal, corneal transplant surgery (DMEK, DSAEK, PKP, DALK), and collagen cross-linking. We also specialize in multiple laser vision correction options including LASIK and PRK.

https://advancedeyeandlaser.com

252 Matlock Road, Suite 348

Mansfield, TX 76063

682.622.0004

Share article on social media or email:

MOBILE, Ala. (PRWEB)
July 08, 2020

The Federal Communications Commission’s Wireline Competition Bureau today approved an additional 25 funding applications for the COVID-19 Telehealth Program, and AltaPointe Health is among the recipients. Health care providers in both urban and rural areas of the country will use the funding to provide telehealth services during the coronavirus pandemic. Since the beginning of the FCC’s COVID-19 Telehealth Program, the agency has approved 539 funding applications in 47 states plus Washington, D.C. and Guam for a total of $200 million in funding—the amount of money provided by Congress in the CARES Act.

“In late March, Congress tasked the FCC with developing from scratch a new $200 million COVID-19 Telehealth Program to help combat COVID-19, support health care providers, and make it easier for Americans to safely access vital healthcare services,” said FCC Chairman Ajit Pai. “And just over three months later, the Commission has approved 539 applications, allocating the full $200 million for worthy projects across the country.”

Telehealth is an effective and innovative way to deliver quality healthcare services. Even before the COVID-19 outbreak, is was evident that the popularity of virtual care is rising and will only continue its upward trend. AltaPointe clinicians provided 13,133 telehealth services across seven counties in Alabama in 22019.

Telehealth removes barriers to care, allowing providers to virtually see patients anytime, anywhere through the use of mobile technologies. AltaPointe’s philosophy is to be the best IT-driven health and human services organization.

To read the full press release

Share article on social media or email:

Dr. Kaliq Chang

Only headaches seem to occur more often on a daily basis to American adults than back pain, which is commonly caused by a pulled muscle, especially in the lower back.

WEST ORANGE, N.J. (PRWEB)
July 08, 2020

Think you’ve pulled a muscle in your back? Join the club, since this injury is one of the most common among adults, according to interventional pain management specialist Kaliq Chang, MD, of Atlantic Spine Center.

“Only headaches seem to occur more often on a daily basis to American adults than back pain, which is commonly caused by a pulled muscle, especially in the lower back,” Dr. Chang explains. “Nevertheless, not everyone knows the signs of a pulled back muscle or more serious symptoms that might emerge that should be checked by a doctor.”

Uncomfortable and often inconvenient – who has time for a problematic muscle? – a pulled muscle in the back also goes by another name: a strained muscle. With the back bearing much of the body’s weight and force while you walk, run, bend and lift things, it’s not surprising that pulled muscles can result.

“Several risk factors can also increase the odds you’ll experience a pulled or strained back muscle,” Dr. Chang notes. “These include carrying extra pounds, having weak back and/or abdominal muscles, and curving your lower back excessively. And pulling a back muscle is easy to do – it can happen after a fall or sudden twist or even from using the same muscle for a long time, like when you bend over to weed a garden.”

Symptoms of a pulled back muscle

If you think you’ve pulled a back muscle, what should you look for? According to Dr. Chang, signs and symptoms can include:

• Sharp or dull pain
• Pain with certain movements
• Stiffness or tightness in the pulled muscle and surrounding area
• Muscle spasms
• Cramping
• Tenderness when the muscle is touched
• Swelling in the affected area
• Pain relief when you rest in certain positions
• Pain shooting down the legs, or numbness/weakness in the feet

Experiencing pain while doing specific things – such as bending over, or even standing still – is a key sign you’ve pulled a back muscle, Dr. Chang points out.

“It’s also common for those with a pulled back muscle to wake up to more pain and stiffness that eases when your muscles warm up and stretch a bit through the day,” he adds.

Serious signs and treatment

While the vast majority of pulled back muscles end up being minor problems that don’t last more than a couple of weeks, Dr. Chang recommends staying vigilant for more serious symptoms indicating you may need medical attention.

What are these more serious signs? “If your pain lasts for longer than 2 weeks, that should prompt you to see your doctor,” he advises. “Also, seek immediate care for back pain that’s accompanied by severe abdominal pain, loss of bladder or bowel control, or an unexplained fever.”

If medical attention is needed, your doctor may use X-rays or other imaging scans to determine what’s happening in or near the spinal cord that’s contributing to your symptoms, Dr. Chang says.

For most people with a pulled back muscle, simple treatments work well to ease pain and transition you to moving more with less discomfort. Dr. Chang says these include over-the-counter pain relievers; applying cold or heat; and gentle stretches several times a day.

Atlantic Spine Center is a nationally recognized leader for endoscopic spine surgery with several locations in NJ and NYC. http://www.atlanticspinecenter.com, http://www.atlanticspinecenter.nyc

Kaliq Chang, MD, is an interventional pain management specialist, double board-certified in interventional pain management and anesthesiology, at Atlantic Spine Center.

Share article on social media or email:

To register, visit www.rssmeetings.org.

It is with much gratitude and appreciation to the speakers and presenters that the RSS is able to provide an on-demand format to educate and disseminate the latest research and scientific advancements in the field of SRS/SBRT and advancing therapies to the global community.

SAN JOSE, Calif. (PRWEB)
July 08, 2020

The Radiosurgery Society (RSS), a non-profit medical society dedicated to advancing the science and clinical practice of radiosurgery, today announced the start of its 2020 RSS Virtual Scientific Meeting. On demand access to the virtual meeting is available to registrants from June 22-December 31, 2020 at http://www.rssmeetings.org.

This year’s meeting will feature access to more than 100 video presentations and electronic posters on stereotactic radiosurgery, stereotactic body radiotherapy and advancing therapies, and feature leading experts in radiation oncology, immunotherapy, neurosurgery, medical physics, and medical oncology from around the world. Registration fees include access to all online sessions and maximum of 23.25 CME/CE credits, along with a complimentary GRID/Lattice, Flash and Microbeam radiation therapies virtual session. To view the 2020 RSS Virtual Meeting Program please visit http://www.rssmeetings.org.

“Due to the COVID-19 pandemic and to protect the health and well-being of meeting attendees and staff, we decided to transition the scheduled in-person 2020 Radiosurgery Society Scientific Meeting to an on-demand virtual meeting. It is with much gratitude and appreciation to the speakers and presenters that the RSS is able to provide an on-demand format to educate and disseminate the latest research and scientific advancements in the field of SRS/SBRT and advancing therapies to the global community,” commented Joanne N. Davis, Ph.D., Executive Director, The Radiosurgery Society. “We are very pleased to work with the Developmental Therapeutics Program and Radiation Research Program in the Division of Cancer Treatment and Diagnosis of the National Cancer Institute, part of the National Institutes of Health to co-sponsor the virtual meeting session Immunology, Immunotherapy and Radiation Oncology, with the goal of educating multi-disciplinary groups on the science of immunotherapy, stereotactic radiation therapy and clinical trial design, and to inspire future working groups and combination clinical trials.”

Abstracts and electronic posters from the meeting are available on the Radiosurgery Society Channel on The Cureus Journal of Medical Science at http://www.cureus.com/channels/theRSS.

This year’s 2020 RSS Virtual Meeting kicked off with two free Showdown Debate webinars: “SBRT for Ultra-Central Lung Tumors,” presented by Gregory Videtic, M.D., Alexander Louie, M.D., Ph.D., and Percy Lee, M.D. held live online on June 9, 2020, and “SBRT vs Brachytherapy for Prostate Cancer,” presented by Glenn Bauman, M.D., Andrew Loblaw, M.D., Shankar Siva, Ph.D., M.B.B.S., F.R.A.N.Z.C.R., and Debra Freeman, M.D., held live on May 26, 2020. Archived videos of these Showdown Debates are available to registrants of the 2020 RSS Virtual Meeting.

The 2020 RSS Virtual Scientific Meeting has been planned and implemented by Amedco LLC and the Radiosurgery Society, enabling participants to receive Continuing Education credits. Amedco LLC designates this live activity for a maximum of 23.25 AMA PRA Category 1 Credits for physicians and 23.25 contact hours for nurses. For Physicists, the virtual meeting has been submitted to the Commission on Accreditation of Medical Physics Education Programs, Inc., and for dosimetrists, his activity has been approved for 23.25 continuing education credits by the Medical Dosimetrist Certification Board.

For more information or to register for the 2020 RSS Virtual Scientific Meeting, go to http://www.rssmeetings.org. Members of the RSS will receive a discount on registration.

About The Radiosurgery Society®

The Radiosurgery Society (RSS) – a non-profit, independent, multi-disciplinary organization of surgeons, radiation oncologists, physicists, and allied professionals, who are dedicated to advancing the science and clinical practice of radiosurgery. Originally formed in 2002 and becoming (501c6) in 2008, the Radiosurgery Society today (http://www.therss.org) represents approximately 600 members who perform stereotactic body radiotherapy and radiosurgery in hospitals and freestanding centers throughout the world.

Share article on social media or email:

The need for pain education is not on hiatus. Patients need us now more than ever to help them negotiate pain and suffering.

MONTCLAIR, N.J. (PRWEB)
July 08, 2020

Due to COVID-19, PAINWeek 2020 will be presented as a live virtual event, September 11-13. Frontline practitioners can look forward to an engaging virtual exhibit hall, scientific poster session, and the unparalleled level of expertise and education practitioners have come to expect from PAINWeek.

Debra Weiner, Executive Vice President, Program Development, remarked, “While the last several months have been challenging, they have also provided an opportunity to expand the availability of continuing medical education in pain management. Barriers to care have been exacerbated by our current pandemic.”

“The need for pain education is not on hiatus,” said senior faculty member Kevin Zacharoff, MD, FACIP, FACPE, FAAP. “Patients need us now more than ever to help them negotiate pain and suffering. This year, the virtual PAINWeek will help attendees familiarize themselves with what the largest multidisciplinary pain conference in the country has to offer—in September and for the rest of the year.” Dr. Zacharoff is Clinical Instructor and Course Director, Pain and Addiction, at the Renaissance School of Medicine at Stony Brook University. He will present two courses: Who Will Love this Child? Advocating for Chronic Pain Patients; and Triple Threat or Epiphany? The Need for a Biopsychosocial Approach to Pain Management.

Over three days, PAINWeek will provide an expansive, multidisciplinary curriculum of 75 CE/CME hours presented by current and emerging thought leaders. An additional 45 hours of certified content will be provided as an enduring, on demand activity for a total of 120 hours.

The International Pelvic Pain Society (IPPS) will be presenting at PAINWeek 2020. “This is the 5th consecutive year of PAINWeek and IPPS collaborating in educating healthcare providers about the complexities surrounding chronic pelvic pain (CPP) conditions in women,” commented Jorge F. Carrillo, MD, a Director on the Board of the IPPS. He will present The Evil Quintuplets: Endometriosis and Other Chronic Pelvic Pain Etiologies. “For the IPPS, it is a privilege to be able to support a program discussing up-to-date topics, bringing awareness and providing helpful clinical tools to assess and treat CPP patients. This year we will discuss trauma informed care approaches and common chronic overlapping pain conditions associated with CPP such as endometriosis, myofascial pain disorders, and bladder pain syndrome.” Other IPPS courses include The First Encounter: A Trauma Informed Care Application; Where East Meets West: Using an Integrative Approach to Treating Overlapping Pelvic Pain Disorders; and Twisted Sister: Musculoskeletal Causes of Chronic Pelvic Pain.

To learn more about PAINWeek or to register for the conference, click here, visit painweek.org, or call (973) 415-5100.

About Global Education Group:

Global Education Group focuses on producing partnership-based CME for healthcare practitioners. The Global team works with a select group of medical education companies, associations, academic institutions and healthcare facilities to develop and accredit live healthcare conferences and workshops as well as online activities. With each partnership or joint providership, Global brings accreditation expertise, project management excellence and grant funding intelligence. Based in Littleton, Colo., Global has accreditation with commendation from the ACCME. Global also holds accreditations to offer continuing education for nurses, nurse practitioners, pharmacists, dietitians, dentists and psychologists. Global is a division of Ultimate Medical Academy.

Share article on social media or email:

Advantage BX Software for Biodex System 4

The high failure of ACL reconstruction and the debate of when to return to play is a very active conversation throughout the world.

SHIRLEY, N.Y. (PRWEB)
July 08, 2020

Following up the initial release of NEW Advantage BX software in January, Biodex Medical Systems, Inc. has enhanced the software with new reporting capabilities focused on getting injured athletes back in play safely. The first-ever Return-to-Play report displays isokinetic test results with clear pass/fail to aid in communication with physicians and athletes throughout the athlete’s recovery.

The new report is a response to the recent resurgence of isokinetic strength testing after ACL reconstruction. Research has shown strength symmetry and balanced hamstring to quadriceps ratios are major components of return-to-play criteria to reduce reinjury after ACL-R. Other criteria include functional test symmetry, agility testing, psychological readiness, and time.

Backed by current research and supported by a panel of experts, the report is designed to give patients and referring physicians the added confidence they are ready to return to play.

“The high failure of ACL reconstruction and the debate of when to return to play is a very active conversation throughout the world,” states Ed Behan, Sr. Vice President, Market Development at Biodex. “The new report is a first, and we’re grateful to have had so many key opinion leaders participating in its creation.”

Live chat with Biodex representatives during the NATA Athletic Trainers’ Virtual Convention, July 13-15, or visit https://www.biodex.com/s4bx for more information.

About Biodex Medical Systems, Inc.

Biodex Medical Systems, Inc. uses science and technology to drive treatment innovation across physical medicine, nuclear medicine and medical imaging categories. With a history of manufacturing and engineering excellence that spans more than 60 years, the Biodex mission is to provide innovative solutions and customer-driven support to medical facilities and wellness centers around the globe. For more information, visit http://www.biodex.com.

Share article on social media or email:

Electron density of fragments from crystal structures of protein-ligand complexes from fragment library screening

Our goal is to discover and develop novel inhibitors that will be broadly effective against SARS-CoV-2 and future SARS strains that will surely emerge.

DOYLESTOWN, Pa. and SAN FRANCISCO (PRWEB)
July 07, 2020

Accelero Biostructures (Accelero) and Mid-Atlantic BioTherapeutics (MABT) are pleased to announce our research collaboration to discover and develop novel coronavirus inhibitors for a broad range of coronaviruses (“pan-coronavirus inhibitors”). Accelero will use its novel and proprietary ABS-OneStepTM platform for high-throughput protein X-ray crystallography-based fragment screening as the hit generation engine for drug discovery. MABT will perform virologic testing and will also assume advanced development of the resulting compounds. In addition, the companies announced today that Accelero has been awarded additional funding from the National Institutes of Health (NIH) to support the discovery phase of this collaboration.

“Our partnership with MABT, and the funding support from NIH, will allow us to utilize our ABS-OneStepTM platform to discover novel chemical matter that targets both the current SARS-CoV-2, as well as potential future coronaviruses, given that COVID-19 is the third coronavirus pandemic or epidemic outbreak in the last 20 years”, said Debanu Das, Ph.D., Accelero Co-Founder and CEO. “After testing and validating ABS-OneStepTM on multiple diverse protein targets, we are now very excited to deploy our platform at this time of global need for novel anti-COVID-19 drug discovery,” said Ashley Deacon, Ph.D., Accelero Co-Founder and CSO.

MABT CEO David Horn, M.D. commented that “There is a clear unmet need for new treatments for this novel coronavirus, SARS-CoV-2, and our goal with this exciting collaboration with Accelero is to leverage their expertise and powerful ABS-OneStepTM platform to discover and develop novel inhibitors that will be broadly effective against SARS-CoV-2 and future SARS strains that will surely emerge.”

About Accelero

Accelero Biostructures (accelerobio.com) was founded in 2015 to capitalize on over 20 years of structural genomics and structural biology expertise using high-throughput protein X-ray crystallography with the ABS-ServicesTM and ABS-OneStepTM platforms. ABS-ServicesTM provides a unified pipeline of protein X-ray crystallography solutions aimed at the pharmaceutical and biotechnology industries to support structure-based drug discovery and protein engineering. ABS-OneStepTM is the next-generation platform for hit generation in early drug discovery to develop novel therapeutics using a fragment-based drug discovery (FBDD) approach. Fragment library screening with ABS-OneStepTM resolves key bottlenecks in conventional FBDD approaches. ABS-OneStepTM provides an extremely sensitive, efficient, experimental, single-step approach for determining fragment hits and their 3D structures using high-throughput protein X-ray crystallography.

About MABT

Mid-Atlantic BioTherapeutics (MABT; mid-atlanticbio.com) was founded in 2011 with the mission of eradicating terrible infectious diseases using a novel, patented technology platform called IMT504. IMT504 harnesses the body’s own immune response to fight off infections that would otherwise be difficult or impossible to treat. IMT504 has shown impressive results in animal safety and efficacy models, and in humans. In addition, MABT continues to explore other treatment options for infectious diseases, including small molecule and antibody approaches.

Disclaimer

Development of the ABS-OneStepTM platform for high-throughput protein X-ray crystallography-based fragment screening has been supported by the National Center for Advancing Translational Sciences of the National Institutes of Health (NIH) under Award Number R43TR001736, and the National Institute of General Medical Sciences of the NIH under Award Number R44GM132796, to Accelero Biostructures Inc. The additional funding from the NIH to Accelero Biostructures Inc. to support the discovery phase of this collaboration is also under Award Number R44GM132796. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.

Share article on social media or email: